-->
The North America stem cell umbilical cord blood market is estimated to witness a rise in revenue from US$ 1,757.60 Mn in 2022 to US$ 7,051.96 Mn by 2031, at a CAGR of 16.5% during the forecast period 2023–2031.
Global molecular FISH testing market was valued at US$ 731.4 million in 2023 and is projected to hit the market valuation of US$ 1,367.4 million by 2032 at a CAGR of 7.2% during the forecast period 2024–2032.
Global spatial OMICS market is projected to experience significant revenue growth, increasing from US$ 280.5 Million in 2022 to US$ 677.8 Million by 2031, with a CAGR of 10.3% during the projection period of 2023–2031.
Chemotherapy-induced peripheral neuropathy (CIPN) is a nerve-damaging side effect of antineoplastic drugs used in chemotherapy, which is a popular cancer treatment. Between 30 & 40 % of people having chemotherapy develop CIPN.
The respiratory syncytial virus (RSV) treatment market was valued at USD 2,387.2 million in 2024 and is projected to reach USD 8,332.5 million by 2033, growing at a CAGR of 14.9% over the forecast period.
The Global Idiopathic Pulmonary Fibrosis Market generated US$ 1,915.0 million in 2020 and is estimated to reach US$ 4,298.8 million by 2030, growing at a compound annual growth rate (CAGR) of 9.4%.